- Home
- LFMD vs ETON Comparison
LFMD vs ETON Comparison
Compare LFMD & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- ETON
- Stock Information
- Founded
- LFMD 1994
- ETON 2017
- Country
- LFMD United States
- ETON United States
- Employees
- LFMD N/A
- ETON N/A
- Industry
- LFMD Medical/Nursing Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- LFMD Health Care
- ETON Health Care
- Exchange
- LFMD Nasdaq
- ETON Nasdaq
- Market Cap
- LFMD 306.7M
- ETON 329.8M
- IPO Year
- LFMD N/A
- ETON 2018
- Fundamental
- Price
- LFMD $5.32
- ETON $12.50
- Analyst Decision
- LFMD Strong Buy
- ETON Strong Buy
- Analyst Count
- LFMD 7
- ETON 3
- Target Price
- LFMD $11.57
- ETON $27.67
- AVG Volume (30 Days)
- LFMD 1.4M
- ETON 222.5K
- Earning Date
- LFMD 05-07-2025
- ETON 05-08-2025
- Dividend Yield
- LFMD N/A
- ETON N/A
- EPS Growth
- LFMD N/A
- ETON N/A
- EPS
- LFMD N/A
- ETON N/A
- Revenue
- LFMD $212,453,838.00
- ETON $39,011,000.00
- Revenue This Year
- LFMD $29.08
- ETON $92.33
- Revenue Next Year
- LFMD $18.81
- ETON $52.62
- P/E Ratio
- LFMD N/A
- ETON N/A
- Revenue Growth
- LFMD 39.27
- ETON 23.29
- 52 Week Low
- LFMD $3.99
- ETON $3.03
- 52 Week High
- LFMD $12.88
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- LFMD 45.04
- ETON 36.53
- Support Level
- LFMD $5.14
- ETON $12.24
- Resistance Level
- LFMD $5.64
- ETON $13.46
- Average True Range (ATR)
- LFMD 0.34
- ETON 0.94
- MACD
- LFMD -0.02
- ETON -0.15
- Stochastic Oscillator
- LFMD 22.43
- ETON 10.03
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.